Amyloid transthyretin (ATTR) amyloidosis occurs when transthyretin (TTR) accumulates and damages organs such as the heart, kidneys, and nerves. It can be inherited or acquired. Hereditary ATTR (hATTR ...

ATTR-CM, a stiffening of the heart that affects pumping blood, is diagnosed through tests like EKGs and MRIs. Genetic testing can help identify if ATTR-CM is hereditary or wild-type. Nuclear ...

The European Commission has approved BridgeBio's acoramidis for life-threatening heart disorder transthyretin amyloidosis cardiomyopathy (ATTR-CM), setting up a market clash with Pfizer. The oral drug ...

AstraZeneca and Ionis are set fair for EU approval of Wainzua, their treatment for polyneuropathy associated with transthyretin-mediated amyloidosis (ATTR), after the EMA's human medicines committee ...

The Transthyretin Amyloidosis - Quality of Life Questionnaire had good convergent validity with established quality-of-life tools, functionality testing, and clinical parameters. The Transthyretin ...

Featured topics and Editors' Picks from all of ACC's JACC Journals. Vutrisiran and All-Cause Mortality, Prognostic Implication of sTTR Levels in ATTR-CM Studies exploring the association between ...

An ACC Concise Clinical Guidance (CCG) report on "Transthyretin Cardiac Amyloidosis Evaluation and Management" provides updated strategies and best practices for clinicians, taking into account ...

Here is a recap of what happened in the search forums today, through the eyes of the Search Engine Roundtable and other search forums on the web. Google AI Mode has better link cards to recipe sites ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at ...

Malicious Chrome extensions tied to ownership transfers push malware and steal data, exposing thousands to credential theft and system compromise.

This week, we continue to see ongoing heated Google Search volatility. I posted the big Google webmaster report for March ...